Edition:
United States

Straumann Holding AG (STMN.S)

STMN.S on Swiss Exchange

370.25CHF
29 Jul 2016
Change (% chg)

CHF-0.50 (-0.13%)
Prev Close
CHF370.75
Open
CHF372.50
Day's High
CHF372.50
Day's Low
CHF367.25
Volume
22,878
Avg. Vol
31,961
52-wk High
CHF389.00
52-wk Low
CHF269.00

STMN.S

Chart for STMN.S

About

Straumann Holding AG is a Switzerland-based company active in the field of implant and restorative dentistry and oral tissue regeneration. In collaboration with clinics, research institutes and universities, the Group researches and develops implants, instruments, computer-aided design/manufacturing (CAD/CAM) prosthetics and... (more)

Overall

Beta: 0.66
Market Cap(Mil.): CHF5,879.19
Shares Outstanding(Mil.): 15.88
Dividend: 4.00
Yield (%): 1.08

Financials

  STMN.S Industry Sector
P/E (TTM): 83.76 41.77 39.28
EPS (TTM): 4.42 -- --
ROI: 7.49 11.59 14.40
ROE: 10.53 13.55 15.47

BRIEF-Straumann Holding takes over distribution of Botiss products in Germany

* Will take over exclusive distribution of botiss products in Germany from Q3 of 2016

Jul 18 2016

BRIEF-Straumann says exercises rights to gain controlling stake in MegaGen

* exercises conversion right and call option to obtain controlling stake in MegaGen

Jul 14 2016

EUROPE RESEARCH ROUNDUP-Luxottica, Bavarian Nordic, Elior

May 4 Securities analysts revised their ratings and price targets on several European companies, including D'Ieteren, NCC and Luxottica, on Wednesday. HIGHLIGHTS * NCC Group : Jefferies starts with buy rating * Elior Group : HSBC cuts to hold from buy * Bavarian Nordic : Cowen & Company starts with outperform rating * Luxottica Group : Raymond James raises to outperform rating * D'Ieteren SA : ING cu

May 04 2016

Straumann lifts 2016 sales forecast after strong first quarter

ZURICH, May 3 Dental implant maker Straumann raised its full-year sales outlook due to strong first-quarter revenue growth in almost all regions and as changes in management in North America to focus on winning new customers was starting to pay off.

May 03 2016

BRIEF-Straumann Holding Q1 group revenue up at CHF 223 million

* Q1 group revenue climbs 15 percent in Swiss francs to 223 million Swiss francs ($233.75 million), including neodent acquisition effect of 3 percent points

May 03 2016

BRIEF-Straumann says to acquire 30 pct stake in Anthogyr

* Says Straumann and France's Anthogyr announce partnership

Feb 25 2016

BRIEF-Straumann says Q4 organic growth strongest since 2008

* Says expects global implant market to grow solidly in 2016 and is confident that it can continue to outperform by achieving organic growth in mid-single-digit range

Feb 25 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Wright Reports
$75.00
Provider : MacroRisk Analytics/EconomicInvestor
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : GlobalData
$300.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.